Nifty
Sensex
:
:
10604.35
35352.61
-36.60 (-0.34%)
-145.83 (-0.41%)

Pharmaceuticals & Drugs

Rating :
58/99

BSE: 532482 | NSE: GRANULES

88.00
0.95 (1.09%)
19-Feb-2019 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  87.40
  •  89.85
  •  86.55
  •  87.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  914053
  •  804.37
  •  123.40
  •  71.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,206.87
  • 11.45
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,069.67
  • 1.15%
  • 1.50

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 44.87%
  • 7.75%
  • 31.62%
  • FII
  • DII
  • Others
  • 3.04%
  • 0.00%
  • 12.72%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.27
  • 8.98
  • 7.47

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.59
  • 11.96
  • 0.18

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 39.26
  • 9.16
  • -2.26

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.85
  • 18.80
  • 18.99

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.49
  • 3.47
  • 3.00

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.44
  • 10.61
  • 10.80

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
631.78
410.73
53.82%
580.87
392.56
47.97%
453.24
384.74
17.80%
503.82
362.17
39.11%
Expenses
518.48
336.70
53.99%
480.34
315.65
52.17%
380.64
308.74
23.29%
460.19
284.82
61.57%
EBITDA
113.30
74.03
53.05%
100.53
76.91
30.71%
72.60
76.00
-4.47%
43.63
77.36
-43.60%
EBIDTM
17.93%
18.02%
17.31%
19.59%
16.02%
19.75%
8.66%
21.36%
Other Income
5.88
0.86
583.72%
4.18
6.83
-38.80%
14.74
1.32
1,016.67%
9.67
1.18
719.49%
Interest
7.47
8.23
-9.23%
7.60
10.41
-26.99%
6.54
8.21
-20.34%
6.21
7.66
-18.93%
Depreciation
27.01
19.60
37.81%
26.53
18.59
42.71%
24.53
17.60
39.38%
20.41
18.00
13.39%
PBT
84.69
47.06
79.96%
70.59
54.74
28.96%
56.27
51.51
9.24%
26.69
52.88
-49.53%
Tax
26.46
16.90
56.57%
23.35
19.26
21.24%
19.11
17.73
7.78%
9.50
16.59
-42.74%
PAT
58.23
30.16
93.07%
47.23
35.48
33.12%
37.16
33.78
10.01%
17.19
36.29
-52.63%
PATM
9.22%
7.34%
8.13%
9.04%
8.20%
8.78%
3.41%
10.02%
EPS
2.37
1.38
71.74%
2.37
1.59
49.06%
2.04
1.61
26.71%
0.81
2.00
-59.50%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
2,169.71
1,684.62
1,410.57
1,357.18
1,292.92
1,095.86
764.37
653.97
475.18
461.09
289.27
Net Sales Growth
39.96%
19.43%
3.93%
4.97%
17.98%
43.37%
16.88%
37.63%
3.06%
59.40%
 
Cost Of Goods Sold
1,233.75
896.32
679.63
725.03
746.95
645.25
466.92
414.36
295.55
275.07
170.17
Gross Profit
935.96
788.30
730.93
632.15
545.97
450.61
297.45
239.60
179.63
186.02
119.11
GP Margin
43.14%
46.79%
51.82%
46.58%
42.23%
41.12%
38.91%
36.64%
37.80%
40.34%
41.18%
Total Expenditure
1,839.65
1,406.20
1,111.73
1,081.29
1,084.31
937.57
679.35
574.68
418.92
399.65
255.78
Power & Fuel Cost
-
48.22
38.67
34.97
45.73
36.70
37.71
26.28
23.07
18.61
9.42
% Of Sales
-
2.86%
2.74%
2.58%
3.54%
3.35%
4.93%
4.02%
4.86%
4.04%
3.26%
Employee Cost
-
165.21
140.19
117.57
106.96
85.84
59.71
45.46
33.38
27.78
17.73
% Of Sales
-
9.81%
9.94%
8.66%
8.27%
7.83%
7.81%
6.95%
7.02%
6.02%
6.13%
Manufacturing Exp.
-
123.40
88.60
66.97
50.89
38.68
24.34
18.90
14.71
30.79
19.63
% Of Sales
-
7.33%
6.28%
4.93%
3.94%
3.53%
3.18%
2.89%
3.10%
6.68%
6.79%
General & Admin Exp.
-
80.48
67.65
60.38
59.84
44.42
26.96
21.31
16.52
18.01
12.14
% Of Sales
-
4.78%
4.80%
4.45%
4.63%
4.05%
3.53%
3.26%
3.48%
3.91%
4.20%
Selling & Distn. Exp.
-
83.08
81.37
67.75
71.70
85.04
61.70
47.62
32.32
28.47
17.11
% Of Sales
-
4.93%
5.77%
4.99%
5.55%
7.76%
8.07%
7.28%
6.80%
6.17%
5.91%
Miscellaneous Exp.
-
9.49
15.61
8.62
2.24
1.64
2.01
0.74
3.36
0.92
17.11
% Of Sales
-
0.56%
1.11%
0.64%
0.17%
0.15%
0.26%
0.11%
0.71%
0.20%
3.31%
EBITDA
330.06
278.42
298.84
275.89
208.61
158.29
85.02
79.29
56.26
61.44
33.49
EBITDA Margin
15.21%
16.53%
21.19%
20.33%
16.13%
14.44%
11.12%
12.12%
11.84%
13.32%
11.58%
Other Income
34.47
10.84
9.93
5.62
4.34
4.31
2.06
1.38
0.80
12.28
1.00
Interest
27.82
33.06
32.26
37.07
32.35
20.43
17.67
16.99
11.99
17.55
15.68
Depreciation
98.48
76.20
71.51
58.40
52.65
29.81
23.08
20.70
18.31
18.57
11.80
PBT
238.24
180.00
204.99
186.03
127.96
112.36
46.32
42.98
26.76
37.60
7.02
Tax
78.42
63.40
65.20
61.15
37.05
37.13
13.76
13.02
5.86
7.22
2.77
Tax Rate
32.92%
35.22%
31.81%
32.87%
28.95%
33.05%
29.71%
30.29%
21.90%
19.20%
39.46%
PAT
159.81
116.60
139.79
124.89
90.91
75.23
32.57
29.95
20.90
30.37
4.25
PAT before Minority Interest
159.81
116.60
139.79
124.89
90.91
75.23
32.57
29.95
20.90
30.37
4.25
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
7.37%
6.92%
9.91%
9.20%
7.03%
6.86%
4.26%
4.58%
4.40%
6.59%
1.47%
PAT Growth
17.76%
-16.59%
11.93%
37.38%
20.84%
130.98%
8.75%
43.30%
-31.18%
614.59%
 
Unadjusted EPS
7.59
5.49
7.52
5.95
4.46
3.72
16.21
14.93
10.42
15.14
2.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
1,304.18
903.60
661.60
431.16
355.96
274.85
245.09
219.78
202.38
174.94
Share Capital
25.38
22.87
21.67
20.43
20.28
20.13
20.06
20.06
21.74
21.74
Total Reserves
1,273.38
878.28
611.13
410.74
335.43
254.41
225.03
199.72
180.64
153.20
Non-Current Liabilities
488.19
187.99
246.62
356.52
343.51
202.00
112.60
58.88
163.74
195.63
Secured Loans
433.13
123.90
183.66
302.59
295.86
174.85
87.30
37.08
135.85
166.05
Unsecured Loans
0.00
0.34
0.55
0.62
13.38
0.65
0.75
0.75
10.85
17.32
Long Term Provisions
7.70
7.25
5.58
4.03
3.97
2.04
1.53
1.19
0.00
0.00
Current Liabilities
844.57
787.13
654.75
415.03
292.54
205.78
213.63
157.11
49.26
34.20
Trade Payables
252.18
215.98
181.10
187.63
135.54
91.84
75.52
51.81
37.56
28.08
Other Current Liabilities
58.67
93.43
79.21
88.98
47.78
23.77
31.39
18.65
8.77
2.77
Short Term Borrowings
525.10
473.83
392.85
124.97
100.91
85.46
102.06
83.15
0.00
0.00
Short Term Provisions
8.62
3.90
1.58
13.45
8.30
4.71
4.66
3.50
2.93
3.35
Total Liabilities
2,636.94
1,878.72
1,562.97
1,202.71
992.01
682.63
571.32
435.77
415.38
404.77
Net Block
776.73
644.34
559.94
616.55
482.47
263.46
250.42
238.62
236.77
243.09
Gross Block
1,199.63
983.66
822.98
843.76
653.90
387.41
354.50
322.61
302.76
290.73
Accumulated Depreciation
422.90
339.32
263.05
227.21
171.43
123.95
104.07
83.99
65.99
47.64
Non Current Assets
1,483.71
1,050.55
744.97
699.69
611.55
388.87
310.52
256.75
239.52
245.41
Capital Work in Progress
514.52
267.43
76.56
62.03
124.56
108.80
29.30
6.85
2.45
2.02
Non Current Investment
156.56
108.23
70.11
0.19
0.19
0.19
0.19
0.30
0.30
0.29
Long Term Loans & Adv.
35.91
30.56
38.37
20.76
4.33
16.42
30.50
10.71
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.15
0.00
0.00
0.12
0.27
0.00
0.00
Current Assets
1,153.23
828.16
818.00
500.36
376.92
288.88
260.26
179.02
174.29
157.40
Current Investments
0.00
0.00
0.00
0.00
0.00
9.46
0.00
0.00
0.00
0.00
Inventories
279.95
269.18
253.72
224.52
174.16
136.48
109.91
75.13
68.63
59.51
Sundry Debtors
617.08
417.70
375.35
136.91
110.91
71.02
95.01
71.61
65.85
63.12
Cash & Bank
115.64
49.80
130.29
65.31
41.75
41.71
31.98
11.99
13.47
12.84
Other Current Assets
140.57
39.83
9.97
71.58
50.10
30.21
23.36
20.29
26.32
21.93
Short Term Loans & Adv.
91.78
51.66
48.68
2.05
28.76
16.93
13.18
12.28
22.70
18.30
Net Current Assets
308.65
41.03
163.25
85.33
84.38
83.09
46.63
21.91
125.03
123.21
Total Assets
2,636.94
1,878.71
1,562.97
1,202.72
992.01
682.64
571.31
435.77
415.38
404.77

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
-0.65
188.24
151.43
150.28
107.95
91.18
25.60
48.56
59.73
-12.28
PBT
180.00
204.99
186.03
127.96
112.36
46.32
42.98
26.76
37.60
7.02
Adjustment
107.45
95.14
92.63
85.37
50.39
41.46
37.74
33.11
24.93
24.16
Changes in Working Capital
-230.03
-52.37
-79.70
-31.34
-31.03
14.60
-43.61
-5.70
3.46
-42.83
Cash after chg. in Working capital
57.42
247.77
198.97
182.00
131.73
102.39
37.11
54.16
65.99
-11.65
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-58.07
-59.53
-47.54
-31.72
-23.78
-11.20
-11.51
-5.60
-6.26
-0.63
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-462.31
-326.09
-161.65
-145.55
-254.63
-127.79
-54.47
-25.09
-13.36
-8.83
Net Fixed Assets
-282.01
-249.86
-75.62
-231.53
-64.60
-89.18
-54.67
-23.22
-10.88
-2.27
Net Investments
-0.01
13.84
-16.48
72.98
-94.69
-17.96
-10.20
0.00
-0.93
0.00
Others
-180.29
-90.07
-69.55
13.00
-95.34
-20.65
10.40
-1.87
-1.55
-6.56
Cash from Financing Activity
528.62
55.87
85.67
18.83
146.72
46.33
48.86
-24.96
-45.73
23.10
Net Cash Inflow / Outflow
65.66
-81.98
75.44
23.56
0.04
9.72
19.99
-1.49
0.64
1.99
Opening Cash & Equivalents
42.37
124.35
54.85
41.75
41.71
31.98
11.99
13.47
12.84
10.85
Closing Cash & Equivalent
108.03
42.37
130.29
65.31
41.75
41.71
31.98
11.99
13.47
12.84

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
51.17
39.40
29.20
20.98
17.36
13.40
12.19
10.96
9.93
8.54
ROA
5.16%
8.12%
9.03%
8.31%
8.98%
5.19%
5.95%
4.91%
7.41%
1.09%
ROE
10.60%
18.23%
23.53%
23.29%
24.20%
12.67%
12.90%
9.98%
16.40%
2.49%
ROCE
11.09%
16.57%
20.16%
18.75%
19.90%
12.95%
14.89%
11.00%
15.67%
6.75%
Fixed Asset Turnover
1.55
1.59
1.66
1.77
2.14
2.11
1.96
1.54
1.58
1.21
Receivable days
111.62
100.84
67.60
33.47
29.73
38.66
45.82
52.00
50.21
62.22
Inventory Days
59.23
66.49
63.11
54.79
50.77
57.37
50.89
54.38
49.89
69.48
Payable days
59.44
64.87
59.99
53.57
43.67
44.19
40.05
38.81
29.80
38.79
Cash Conversion Cycle
111.41
102.46
70.72
34.69
36.83
51.84
56.66
67.57
70.30
92.90
Total Debt/Equity
0.75
0.73
1.01
1.14
1.25
1.00
0.83
0.63
0.73
1.06
Interest Cover
6.44
7.36
6.02
4.96
6.50
3.62
3.53
3.23
3.14
1.45

News Update:


  • Granules India to set up wholly-owned subsidiary in Ireland
    30th Jan 2019, 15:09 PM

    The Board of Directors of the company at their meeting held on January 29, 2018, approved the same

    Read More
  • Granules India reports 72% rise in Q3 consolidated net profit
    30th Jan 2019, 09:55 AM

    Total consolidated income of the company increased by 54.92% at Rs 637.65 crore for Q3FY19

    Read More
  • Granules India’s arm gets USFDA nod for ANDA
    27th Nov 2018, 11:13 AM

    Granules Pharmaceuticals shall market and distribute the product shortly

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.